ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 37 filers reported holding ELEVATION ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,709 | +100.1% | 1,952,032 | 0.0% | 0.24% | +96.8% |
| Q4 2022 | $1,854 | -99.9% | 1,952,032 | 0.0% | 0.12% | -19.5% |
| Q3 2022 | $2,206,000 | -20.5% | 1,952,032 | -1.6% | 0.15% | -26.7% |
| Q2 2022 | $2,776,000 | -44.5% | 1,983,168 | +0.0% | 0.21% | -45.3% |
| Q1 2022 | $4,998,000 | -58.1% | 1,983,165 | 0.0% | 0.38% | -45.9% |
| Q4 2021 | $11,939,000 | -21.1% | 1,983,165 | 0.0% | 0.71% | +15.4% |
| Q3 2021 | $15,140,000 | -40.8% | 1,983,165 | 0.0% | 0.62% | -29.2% |
| Q2 2021 | $25,566,000 | – | 1,983,165 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 2,834,910 | $38,470,000 | 6.16% |
| venBio Partners LLC | 2,608,167 | $35,393,000 | 4.18% |
| Samsara BioCapital, LLC | 932,239 | $12,650,000 | 1.56% |
| Cormorant Asset Management, LP | 1,983,165 | $25,566,000 | 0.87% |
| BVF INC/IL | 1,590,291 | $21,580,000 | 0.81% |
| Boxer Capital, LLC | 1,341,530 | $18,205,000 | 0.64% |
| Ghost Tree Capital, LLC | 100,000 | $1,357,000 | 0.37% |
| CAXTON CORP | 39,586 | $537,000 | 0.37% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,999,514 | $26,456,000 | 0.35% |
| Vivo Capital, LLC | 496,843 | $6,742,000 | 0.29% |